Table 1 Mortality at 12 months by baseline characteristic
Baseline Clinical Characteristics | 1-year mortality | N = XXX (%) | ||
|---|---|---|---|---|
Dead n (row percentage%) | Alive N (row percentage %) | |||
Gender | Male | 177 (39%) | 276 (61%) | 453 (67%) |
Female | 105 (47%) | 118 (53%) | 223 (33%) | |
Age | ≤ 64 | 57 (31%) | 126 (69%) | 183 (27%) |
65–79 | 119 (38%) | 198 (62%) | 317 (47%) | |
≥ 80 | 106 (60%) | 70 (40%) | 176 (26%) | |
Asbestos exposure | Unexposed | 200 (45%) | 246 (55%) | 446 (66%) |
Suspected exposed | 82 (36%) | 148 (64%) | 230 (34%) | |
Diagnostic category | Benign effusion related to organ failure | 37 (30%) | 86 (70%) | 123 (18%) |
Malignant effusion | 227 (62%) | 137 (38%) | 364 (54%) | |
Infective aetiology | 5 (9%) | 49 (91%) | 54 (8%) | |
Inflammatory aetiology | 6 (6%) | 83 (94%) | 89 (26%) | |
Other | 7 (15%) | 39 (85%) | 46 (7%) | |
Frailty | Not frail (mFI ≤ 0.2) | 192 (40%) | 283 (60%) | 475 (71%) |
Frail (mFI ≥ 0.4) | 88 (45%) | 106 (55%) | 194 (29%) | |
WHO PS | 0 | 21 (18%) | 95 (82%) | 116 (18%) |
1 | 106 (37%) | 182 (63%) | 288 (44%) | |
2 | 88 (51%) | 83 (49%) | 171 (26%) | |
3 | 50 (70%) | 21 (30%) | 71 (11%) | |
4 | 4 (100%) | 0 (0%) | 4 (1%) | |
Functional dependence | 107 (66%) | 56 (34%) | 163 (24%) | |
DM | 43 (37%) | 72 (63%) | 115 (17%) | |
Treated HTN | 84 (38%) | 137 (62%) | 221 (33%) | |
COPD | 19 (38%) | 31 (62%) | 50 (7%) | |
CHF | 42 (31%) | 92 (69%) | 134 (20%) | |